1-7 of 7
Meyling H. Cheok
Close
Sort by
Journal Articles

Tetraspanin CD81 Supports Cancer Stem Cell Function and Represents a Therapeutic Vulnerability in Acute Myeloid Leukemia

Fanny Gonzales, Pauline Peyrouze, Thomas Boyer, Soizic Guihard, Francois Sevrin, Djohana Laurent, Adriana Plesa, Adeline Barthelemy, Antonino Bongiovanni, Claude Preudhomme, Nicolas Duployez, Celine Berthon, Christophe Roumier, Meyling H Cheok
Journal: Blood
Blood (2023) 142 (Supplement 1): 168.
https://doi.org/10.1182/blood-2023-186957
Published: 2023
Journal Articles

Clofarabine-Based Consolidation Improves Relapse-Free Survival of Patients with Acute Myeloid Leukemia with Complex or Micro-Complex Karyotype: Results from the Randomized ALFA-0702 Study

Laurène Fenwarth, MSc, MD, Nicolas Duployez, PharmD, PhD, Xavier Thomas, MD, Nicolas Boissel, MD PhD, Sandrine Geffroy, PhD, Alice Marceau-Renaut, PharmD, Denis Caillot, MD, Emmanuel Raffoux, MD, Emilie Lemasle, MD, Jean-Pierre Marolleau, MD PhD, Céline Berthon, MD PhD, Meyling H. Cheok, MSPharm, PhD, Pauline Peyrouze, Arnaud Pigneux, MD PhD, Norbert Vey, Karine Celli-Lebras, CRA, Christine Terré, PharmD, PhD, Claude Preudhomme, PharmD, PhD, Herve Dombret, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 465.
https://doi.org/10.1182/blood.V130.Suppl_1.465.465
Published: 2017
Journal Articles

Architectural and Functional Heterogeneity of Hematopoietic Stem/Progenitor Cells in Non-Del(5q) Myelodysplastic Syndromes

Virginie Chesnais, Marie-laure Arcangeli, PhD, Caroline Delette, Alice Rousseau, M'boyba Khadija Diop, Andrea Lefevre, Meyling H. Cheok, MSPharm, PhD, Nicolas Chapuis, PharmD, PhD, Laurence Legros, MD PhD, Sophie Raynaud, MD, Lise Willems, MD PhD, Didier Bouscary, MD PhD, Evelyne Lauret, PhD, Olivier A. Bernard, PhD, Olivier Kosmider, MD PhD, Francoise Pflumio, PhD, Michaela Fontenay, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3153.
https://doi.org/10.1182/blood.V128.22.3153.3153
Published: 2016
Journal Articles

Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols

Clinical Trials & Observations
Amy Holleman, Monique L. den Boer, Meyling H. Cheok, Karin M. Kazemier, Deqing Pei, James R. Downing, Gritta E. Janka-Schaub, Ulrich Göbel, Ulrike B. Graubner, Ching-Hon Pui, William E. Evans, Rob Pieters
Journal: Blood
Blood (2006) 108 (6): 1984–1990.
https://doi.org/10.1182/blood-2006-04-015990
Published: 2006
Journal Articles

The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia

Clinical Trials & Observations
Amy Holleman, Monique L. den Boer, Renée X. de Menezes, Meyling H. Cheok, Cheng Cheng, Karin M. Kazemier, Gritta E. Janka-Schaub, Ulrich Göbel, Ulrike B. Graubner, William E. Evans, Rob Pieters
Journal: Blood
Blood (2006) 107 (2): 769–776.
https://doi.org/10.1182/blood-2005-07-2930
Published: 2006
Includes: Supplemental data
Journal Articles

Genetic Polymorphisms in the Promoter Region of the beta-2 Adrenergic Receptor Are Associated with the Early Response of Acute Lymphoblastic Leukemia to Chemotherapy.

Meyling H. Cheok, PhD, Cong Ding, MS, Wenjian Yang, PhD, Somas Das, PhD, Dario Campana, MD, Cheng Cheng, PhD, Edwin H. Cook, MD, Ching-Hon Pui, MD, Mary V. Relling, PharmD, William E. Evans, PharmD
Journal: Blood
Blood (2004) 104 (11): 1959.
https://doi.org/10.1182/blood.V104.11.1959.1959
Published: 2004
Journal Articles

Folate Pathway Gene Expression Differs in Genetic Subtypes of Acute Lymphoblastic Leukemia and Influences Methotrexate Pharmacodynamics.

Leo Kager, MD, Meyling H. Cheok, PhD, Wenjian Yang, PhD, Gianluigi Zaza, MD, Ching-Hon Pui, MD, James R. Downing, MD, Mary V. Relling, PharmD, William E. Evans, PharmD
Journal: Blood
Blood (2004) 104 (11): 452.
https://doi.org/10.1182/blood.V104.11.452.452
Published: 2004